Gene expression profiles of adult peripheral and cord blood mononuclear cells altered by lipopolysaccharide

Neonatology

Volumn 93, Issue 2, 2008, Pages 87-100

  Koch, Lutz ^a   Linderkamp, Otwin ^a   Ittrich, Carina ^b   Benner, Axel ^b   Poeschl, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adult peripheral blood mononuclear cells; Cord blood mononuclear cells; Gene expression profile; Lipopolysaccharide; Sepsis

Indexed keywords

CHEMOKINE; CYTOKINE; DIMETHYLALLYLTRANSFERASE; HEMOGLOBIN; HEMOGLOBIN EPSILON 1; LIPOPOLYSACCHARIDE; MALATE DEHYDROGENASE; MALATE DEHYDROGENASE (DECARBOXYLATING); RNA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE INTERACTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MONONUCLEAR CELL; NEWBORN; NORMAL HUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FAMILY; RNA ISOLATION; SEPSIS; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ADULT; ANTIBODIES, BACTERIAL; CELL CYCLE PROTEINS; CHEMOKINES; CYTOKINES; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; SEPSIS; TRANSCRIPTION FACTORS;

NEGIBACTERIA;

EID: 38949196369     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000107350     Document Type: Article

References (53)

1. Groll AH, Meiser A, Weise M, Rettwitz-Volk W, von Loewenich V, Gussetis ES, Kornhuber B: Interleukin 6 as early mediator in neonatal sepsis. Pediatr Infect Dis J 1992;11:496-498.
2. Wolach B: Neonatal sepsis: pathogenesis and supportive therapy. Semin Perinatol 1997;21:28-38.
3. Barton P, Kalil AC, Nadel S, Goldstein B, Okhuysen-Cawley R, Brilli RJ, Takano JS, Martin LD, Quint P, Yeh TS, Dalton HJ, Gessouron MR, Brown KE, Betts H, Levin M, Macias WL, Small DS, Wyss VL, Bates BM, Utterback BG, Giroir BP: Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics 2004;113:7-17.
4. Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V: Sepsis in neonates and children: definitions, epidemiology, and outcome. Pediatr Emerg Care 1997;13:277-281.
5. Levy O: Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-390.
6. Cairo MS: Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis. Am J Dis Child 1989;143:40-46.
7. Chalmers IM, Janossy G, Contreras M, Navarrete C: Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998;92:11-18.
8. Lewis DB, Wilson CB: Developmental immunology and role of host defenses in neonatal susceptibility to infection; in Remington JS, Klein JO (eds): Infectious Diseases of the Fetus and Neonate. Philadelphia, Saunders, 1995, pp 20-98.
9. Poschl JM, Ruef P, Linderkamp O: Deformability of passive and activated neutrophils in children with Gram-negative septicemia. Scand J Clin Lab Invest 2005;65:333-339.
10. Zilow G, Zilow EP, Burger R, Linderkamp O: Complement activation in newborn infants with early onset infection. Pediatr Res 1993;34:199-203.
11. Ansart-Pirenne H, Soulimani N, Tartour E, Blot P, Sterkers G: Defective IL2 gene expression in newborn is accompanied with impaired tyrosine- phosphorylation in T cells. Pediatr Res 1999;45:409-413.
12. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS: Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996;88:945-954.
13. Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD: Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res 1992;31:18-21.
14. Scott ME, Kubin M, Kohl S: High level interleukin-12 production, but diminished interferon-γ production, by cord blood mononuclear cells. Pediatr Res 1997;41:547-553.
15. Weatherstone KB, Rich EA: Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 1989;25:342-346.
16. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R: Role of MyD88 in diminished tumor necrosis factor α production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004;72:1223-1229.
17. Schultz C, Rott C, Richter N, Bucsky P: Intracytoplasmic detection of cytokines in neonatal lymphocytes and monocytes by flow cytometry. Blood 1999;93:3566-3567.
18. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, Richter K, Tawfeek MS, Clad A, Brandis M: Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-α, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998;44:469-477.
19. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR: The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn. J Immunol 2006;177:1956-1966.
20. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, Levy O: Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-α production in vitro and in vivo. Pediatr Res 2006;60:205-209.
21. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ: Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000;165:618-622.
22. Team RDC: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2004.
23. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
24. Wu Z, Irizarry RA, Gentleman RC, Martinez-Murillo F, Spencer F: A model-based background adjustment for oligonucleotide expression in arrays. J Am Stat Assoc 2004;99:909-917.
25. Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article 3.
26. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
27. Berner R, Welter P, Brandis M: Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr Res 2002;51:304-309.
28. Hebra A, Strange P, Egbert JM, Ali M, Mullinax A, Buchanan E: Intracellular cytokine production by fetal and adult monocytes. J Pediatr Surg 2001;36:1321-1326.
29. Saez-Llorens X, McCracken GH Jr: Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr 1993;123:497-508.
30. Dembinski J, Behrendt D, Reinsberg J, Bartmann P: Endotoxin-stimulated production of IL-6 and IL-8 is increased in short-term cultures of whole blood from healthy term neonates. Cytokine 2002;18:116-119.
31. Jiang H, Van De Ven C, Satwani P, Baxi LV, Cairo MS: Differential gene expression patterns by oligonucleotide microarray of basal versus lipopolysaccharide-activated monocytes from cord blood versus adult peripheral blood. J Immunol 2004;172:5870-5879.
32. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-975.
33. Baldwin AS Jr: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683.
34. Schaub A, Futterer A, Pfeffer K: PUMA-G, an IFN-γ -inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol 2001;31:3714-3725.
35. Balk RA: Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000;16:179-192.
36. Hebert PC, Drummond AJ, Singer J, Bernard GR, Russell JA: A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 1993;104:230-235.
37. Matute-Bello G, Liles WC, Radella F 2nd, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR: Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 2000;28:1-7.
38. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL: Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 2001;15:879-892.
39. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-1725.
40. Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-1635.
41. Wajant H: The Fas signaling pathway: more than a paradigm. Science 2002;296:1635-1636.
42. Chung CS, Xu YX, Wang W, Chaudry IH, Ayala A: Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg 1998;133:1213-1220.
43. Sabelko-Downes KA, Russell JH: The role of fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol 2000;12:330-335.
44. De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler E, Cardier JE: Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 2004;125:2238-2246.
45. Marsik C, Halama T, Cardona F, Wlassits W, Mayr F, Pleiner J, Jilma B: Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock 2003;20:493-496.
46. L'Her E, Sebert P: A global approach to energy metabolism in an experimental model of sepsis. Am J Respir Crit Care Med 2001;164:1444-1447.
47. Brealey D, Singer M: Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003;5:365-371.
48. DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, Meltzer PS, Trent JM: Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 1997;15:453-457.
49. Frenkel R: Regulation and physiological functions of malic enzymes. Curr Top Cell Regul 1975;9:157-181.
50. Goodridge AG, Klautky SA, Fantozzi DA, Baillie RA, Hodnett DW, Chen W, Thurmond DC, Xu G, Roncero C: Nutritional and hormonal regulation of expression of the gene for malic enzyme. Prog Nucleic Acid Res Mol Biol 1996;52:89-122.
51. Baralle FE, Shoulders CC, Proudfoot NJ: The primary structure of the human ε-globin gene. Cell 1980;21:621-626.
52. Gale RE, Clegg JB, Huehns ER: Human embryonic haemoglobins Gower 1 and Gower 2. Nature 1979;280:162-164.
53. Hamilton BJ, Burns CM, Nichols RC, Rigby WF: Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation. J Biol Chem 1997;272:28732-28741.